Press Release

PharmaLink Announces Execution of Returns Processing Service Agreement with Merck

(LARGO, FL) PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced today a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC (Merck). The new Returns Processing Service Agreement is expected to enhance the returns process for downstream customers while maintaining the integrity of supply chain security.

PharmaLink Announces Execution of Returns Processing Service Agreement with Merck Read More »

PharmaLink Announces Acquisition of PharmaReturns

(LARGO, FL) PharmaLink, Inc., a leading pharmaceutical reverse distributor, announced today its acquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. In addition to expanding its national account base with top tier clients, the purchase provides PharmaLink with an innovative technology platform for returns processing that adds Artificial Intelligence (AI) and new levels of customization to the reverse distribution process for pharmaceutical manufacturers. The Internet Managed Product Returns Solution (IMPRS) currently supports returns processing operations for over 400 Pharmaceutical manufacturers in the United States.

PharmaLink Announces Acquisition of PharmaReturns Read More »

PharmaLink Expands Operations Facility to Meet Growing Demand

Largo, FL. – February 2023- Industry leading pharmaceutical returns management company, PharmaLink, Inc. announced today that it has completed its second expansion of its current headquarters and processing location in Largo, Florida. The expansion increases its overall capacity to 91,000 square feet at its current facility and will substantially augment its processing and product storage capacity.

PharmaLink Expands Operations Facility to Meet Growing Demand Read More »

PharmaLink Announces Facility Expansion to Accommodate Growth

PharmaLink Announces Facility Expansion to Accommodate Growth Largo, FL.– December 17, 2019 — PharmaLink, Inc., an industry leading pharmaceutical reverse distribution company, is announcing a series of initiatives designed to accommodate the changing dynamics of its business and the industry.  Today, PharmaLink announced that it started Phase 1 of its expansion project in response to

PharmaLink Announces Facility Expansion to Accommodate Growth Read More »

Skip to content